Henry Schein’s (HSIC) “Outperform” Rating Reaffirmed at Barrington Research

Barrington Research reissued their outperform rating on shares of Henry Schein (NASDAQ:HSIC) in a research note issued to investors on Wednesday morning,Benzinga reports. They currently have a $90.00 price objective on the stock.

Other research analysts have also issued reports about the stock. Wells Fargo & Company began coverage on shares of Henry Schein in a report on Friday, February 14th. They issued an “equal weight” rating and a $80.00 target price on the stock. Jefferies Financial Group upped their price objective on shares of Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research note on Thursday, January 23rd. Bank of America raised shares of Henry Schein from an “underperform” rating to a “buy” rating and upped their price objective for the company from $69.00 to $84.00 in a research note on Monday, January 6th. Mizuho assumed coverage on shares of Henry Schein in a research report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 target price for the company. Finally, StockNews.com raised shares of Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Six investment analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, Henry Schein presently has an average rating of “Moderate Buy” and an average target price of $81.10.

Henry Schein Price Performance

Shares of NASDAQ HSIC opened at $72.54 on Wednesday. The firm has a market capitalization of $9.04 billion, a P/E ratio of 29.85, a PEG ratio of 2.13 and a beta of 0.91. Henry Schein has a one year low of $63.67 and a one year high of $82.63. The company’s fifty day moving average is $74.28 and its two-hundred day moving average is $72.43. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing the consensus estimate of $1.23 by ($0.04). Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business had revenue of $3.19 billion during the quarter, compared to analysts’ expectations of $3.25 billion. During the same quarter in the prior year, the firm earned $0.66 earnings per share. Henry Schein’s quarterly revenue was up 5.8% on a year-over-year basis. Analysts forecast that Henry Schein will post 4.74 EPS for the current fiscal year.

Institutional Investors Weigh In On Henry Schein

Several large investors have recently added to or reduced their stakes in the stock. Mirae Asset Global Investments Co. Ltd. increased its holdings in shares of Henry Schein by 32.5% during the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 12,204 shares of the company’s stock valued at $894,000 after purchasing an additional 2,992 shares during the period. Deroy & Devereaux Private Investment Counsel Inc. increased its holdings in shares of Henry Schein by 0.7% during the third quarter. Deroy & Devereaux Private Investment Counsel Inc. now owns 47,055 shares of the company’s stock valued at $3,430,000 after purchasing an additional 325 shares during the period. Stephens Investment Management Group LLC grew its holdings in Henry Schein by 8.9% during the third quarter. Stephens Investment Management Group LLC now owns 179,716 shares of the company’s stock worth $13,101,000 after acquiring an additional 14,631 shares during the period. Farther Finance Advisors LLC grew its holdings in Henry Schein by 58.9% during the third quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock worth $68,000 after acquiring an additional 346 shares during the period. Finally, Private Management Group Inc. acquired a new position in Henry Schein during the third quarter worth about $24,176,000. 96.62% of the stock is owned by institutional investors and hedge funds.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.